Global Health Share Price
1325.80+0.00 (+2.11%)
+4.02% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
APOLLOHOSPNSE
MAXHEALTHNSE
MANIPALHOSNSE
ASTERDMNSE
FORTISNSE
NHNSE
MEDANTANSE
LALPATHLABNSE
KIMSNSE
AGARWALEYENSE
Global Health Share Price
1325.80+0.00 (+2.11%)
+4.02% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| 12% | 25% | 18% | 19% |
| 13% | 81% | 20% | 15% |
| - | - | 18% | 4% |
| 10% | 16% | 16% | 15% |
Peer Comparison
Symbol
APOLLOHOSP
MAXHEALTH
MANIPALHOS
ASTERDM
FORTIS
NH
MEDANTA
LALPATHLAB
KIMS
AGARWALEYE
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 8,440 | ₹121067 Cr | 57.94 | 40.39 | 207.67 | ₹1942 Cr |
| 895.5 | ₹85955 Cr | 62.26 | 4.26 | 19.36 | ₹1442 Cr |
| 645.2 | ₹85953 Cr | 96.33 | 1.96 | 11.95 | ₹892 Cr |
| 681.35 | ₹58742 Cr | 184.33 | 0.31 | 6.76 | ₹388 Cr |
| 785.55 | ₹57377 Cr | 54.75 | 3.53 | 20.1 | ₹1042 Cr |
| 1,870.6 | ₹37545 Cr | 43.72 | 14.73 | 71.14 | ₹806 Cr |
| 1,325.8 | ₹34919 Cr | 62.78 | 5.91 | 29.85 | ₹556 Cr |
| 1,925.7 | ₹31682 Cr | 58.46 | 10.11 | 42.51 | ₹505 Cr |
| 731.75 | ₹30276 Cr | 148.2 | 1.04 | 12.74 | ₹241 Cr |
| 511 | ₹16301 Cr | 109.87 | 1.43 | 13.88 | ₹133 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹1469 Cr | ₹1304 Cr | ₹1159 Cr | ₹1121 Cr | ₹1099 Cr | ₹1031 Cr | ₹931 Cr | ₹943 Cr | ₹957 Cr | ₹861 Cr | ₹809 Cr | ₹836 Cr | ₹850 Cr | ₹780 Cr | ₹707 Cr | ₹694 Cr | ₹679 Cr | ₹617 Cr | ₹521 Cr | ₹583 Cr |
| ₹24 Cr | ₹22 Cr | ₹37 Cr | ₹22 Cr | ₹20 Cr | ₹20 Cr | ₹23 Cr | ₹16 Cr | ₹18 Cr | ₹22 Cr | ₹27 Cr | ₹18 Cr | ₹14 Cr | ₹15 Cr | ₹25 Cr | ₹12 Cr | ₹16 Cr | ₹9 Cr | ₹12 Cr | ₹10 Cr |
| ₹1493 Cr | ₹1326 Cr | ₹1196 Cr | ₹1143 Cr | ₹1119 Cr | ₹1051 Cr | ₹954 Cr | ₹959 Cr | ₹975 Cr | ₹883 Cr | ₹836 Cr | ₹855 Cr | ₹865 Cr | ₹794 Cr | ₹732 Cr | ₹706 Cr | ₹695 Cr | ₹627 Cr | ₹533 Cr | ₹593 Cr |
| ₹1170 Cr | ₹1086 Cr | ₹982 Cr | ₹965 Cr | ₹918 Cr | ₹849 Cr | ₹756 Cr | ₹754 Cr | ₹778 Cr | ₹721 Cr | ₹675 Cr | ₹664 Cr | ₹674 Cr | ₹636 Cr | ₹578 Cr | ₹573 Cr | ₹560 Cr | ₹521 Cr | ₹476 Cr | ₹481 Cr |
| ₹394 Cr | ₹309 Cr | ₹281 Cr | ₹239 Cr | ₹251 Cr | ₹247 Cr | ₹248 Cr | ₹254 Cr | ₹247 Cr | ₹208 Cr | ₹207 Cr | ₹234 Cr | ₹234 Cr | ₹199 Cr | ₹192 Cr | ₹172 Cr | ₹172 Cr | ₹142 Cr | ₹92 Cr | ₹146 Cr |
| ₹28 Cr | ₹27 Cr | ₹27 Cr | ₹22 Cr | ₹17 Cr | ₹14 Cr | ₹15 Cr | ₹16 Cr | ₹16 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹20 Cr | ₹18 Cr | ₹20 Cr | ₹21 Cr | ₹18 Cr | ₹19 Cr | ₹28 Cr | ₹18 Cr |
| ₹295 Cr | ₹213 Cr | ₹187 Cr | ₹120 Cr | ₹200 Cr | ₹208 Cr | ₹133 Cr | ₹189 Cr | ₹181 Cr | ₹144 Cr | ₹143 Cr | ₹172 Cr | ₹171 Cr | ₹141 Cr | ₹133 Cr | ₹112 Cr | ₹117 Cr | ₹87 Cr | ₹29 Cr | ₹95 Cr |
| ₹219 Cr | ₹157 Cr | ₹142 Cr | ₹95 Cr | ₹158 Cr | ₹159 Cr | ₹101 Cr | ₹143 Cr | ₹131 Cr | ₹106 Cr | ₹127 Cr | ₹124 Cr | ₹125 Cr | ₹102 Cr | ₹101 Cr | ₹81 Cr | ₹86 Cr | ₹59 Cr | ₹18 Cr | ₹70 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | — |
| ₹54 Cr | ₹54 Cr | ₹54 Cr | ₹54 Cr | ₹51 Cr | ₹82 Cr | ₹82 Cr | ₹82 Cr | ₹81 Cr | ₹81 Cr | ₹81 Cr | ₹80 Cr |
| ₹16 Cr | ₹25 L | ₹4 Cr | ₹5 Cr | ₹6 Cr | ₹32 Cr | ₹48 Cr | ₹54 Cr | ₹74 Cr | ₹42 Cr | ₹12 Cr | ₹5 Cr |
| ₹3891 Cr | ₹3332 Cr | ₹2848 Cr | ₹2369 Cr | ₹1560 Cr | ₹1268 Cr | ₹1219 Cr | ₹1170 Cr | ₹1062 Cr | ₹1016 Cr | ₹964 Cr | ₹794 Cr |
| ₹3891 Cr | ₹3332 Cr | ₹2848 Cr | ₹2369 Cr | ₹1560 Cr | ₹1268 Cr | ₹1219 Cr | ₹1170 Cr | ₹1062 Cr | ₹1016 Cr | ₹964 Cr | ₹794 Cr |
| ₹3962 Cr | ₹3386 Cr | ₹2906 Cr | ₹2428 Cr | ₹1616 Cr | ₹1382 Cr | ₹1350 Cr | ₹1305 Cr | ₹1217 Cr | ₹1139 Cr | ₹1057 Cr | ₹879 Cr |
| ₹23 Cr | ₹1 Cr | -₹3 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹49 L | ₹51 L |
| ₹601 Cr | ₹264 Cr | ₹236 Cr | ₹659 Cr | ₹717 Cr | ₹551 Cr | ₹541 Cr | ₹449 Cr | ₹229 Cr | ₹24 Cr | ₹113 Cr | ₹40 Cr |
| ₹0 | ₹0 | ₹48 Cr | ₹78 Cr | ₹50 Cr | ₹26 Cr | ₹65 Cr | ₹140 Cr | ₹107 Cr | ₹108 Cr | ₹0 | ₹0 |
| -₹16 Cr | -₹33 Cr | -₹37 Cr | -₹7 Cr | -₹28 Cr | -₹26 Cr | ₹8 Cr | ₹31 Cr | ₹48 Cr | ₹57 Cr | ₹61 Cr | ₹62 Cr |
| ₹579 Cr | ₹430 Cr | ₹415 Cr | ₹305 Cr | ₹291 Cr | ₹287 Cr | ₹309 Cr | ₹25 Cr | ₹31 Cr | ₹36 Cr | ₹2 Cr | ₹6 Cr |
| ₹114 Cr | ₹66 Cr | ₹58 Cr | ₹54 Cr | ₹555 Cr | ₹461 Cr | ₹86 Cr | ₹31 Cr | ₹17 Cr | ₹17 Cr | ₹13 Cr | ₹11 Cr |
| ₹1278 Cr | ₹727 Cr | ₹719 Cr | ₹1089 Cr | ₹1586 Cr | ₹1300 Cr | ₹1009 Cr | ₹676 Cr | ₹432 Cr | ₹242 Cr | ₹189 Cr | ₹118 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — |
| ₹242 Cr | ₹195 Cr | ₹187 Cr | ₹195 Cr | ₹134 Cr | ₹132 Cr | ₹131 Cr | ₹126 Cr | ₹106 Cr | ₹104 Cr | ₹92 Cr | ₹83 Cr |
| ₹355 Cr | ₹377 Cr | ₹394 Cr | ₹352 Cr | ₹266 Cr | ₹245 Cr | ₹208 Cr | ₹143 Cr | ₹134 Cr | ₹109 Cr | ₹110 Cr | ₹108 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹67 Cr | ₹30 Cr | ₹11 Cr | ₹0 |
| ₹30 Cr | ₹47 Cr | ₹36 Cr | ₹26 Cr | ₹19 Cr | ₹28 Cr | ₹19 Cr | ₹10 Cr | ₹27 Cr | ₹28 Cr | ₹26 Cr | ₹23 Cr |
| ₹627 Cr | ₹619 Cr | ₹618 Cr | ₹573 Cr | ₹419 Cr | ₹405 Cr | ₹358 Cr | ₹279 Cr | ₹334 Cr | ₹272 Cr | ₹238 Cr | ₹214 Cr |
| ₹5889 Cr | ₹4733 Cr | ₹4243 Cr | ₹4090 Cr | ₹3622 Cr | ₹3087 Cr | ₹2716 Cr | ₹2259 Cr | ₹1984 Cr | ₹1653 Cr | ₹1485 Cr | ₹1212 Cr |
| ₹100 Cr | ₹89 Cr | ₹52 Cr | ₹47 Cr | ₹24 Cr | ₹13 Cr | ₹12 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹0 | ₹0 |
| ₹631 Cr | ₹328 Cr | ₹419 Cr | ₹842 Cr | ₹838 Cr | ₹645 Cr | ₹622 Cr | ₹610 Cr | ₹423 Cr | ₹183 Cr | ₹133 Cr | ₹48 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — |
| ₹5077 Cr | ₹3605 Cr | ₹3146 Cr | ₹2877 Cr | ₹2458 Cr | ₹2173 Cr | ₹2141 Cr | ₹1359 Cr | ₹1328 Cr | ₹1126 Cr | ₹1223 Cr | ₹991 Cr |
| ₹1283 Cr | ₹1091 Cr | ₹910 Cr | ₹827 Cr | ₹682 Cr | ₹557 Cr | ₹438 Cr | ₹329 Cr | ₹239 Cr | ₹154 Cr | ₹309 Cr | ₹239 Cr |
| ₹3795 Cr | ₹2514 Cr | ₹2236 Cr | ₹2050 Cr | ₹1776 Cr | ₹1616 Cr | ₹1703 Cr | ₹1030 Cr | ₹1089 Cr | ₹972 Cr | ₹914 Cr | ₹752 Cr |
| ₹132 Cr | ₹529 Cr | ₹386 Cr | ₹327 Cr | ₹439 Cr | ₹464 Cr | ₹382 Cr | ₹656 Cr | ₹317 Cr | ₹10 Cr | ₹12 Cr | ₹23 Cr |
| ₹3 Cr | ₹3 Cr | ₹5 L | ₹5 L | ₹5 L | ₹5 L | ₹0 | ₹0 | ₹5 Cr | ₹5 Cr | ₹0 | ₹0 |
| ₹3 Cr | ₹3 Cr | ₹5 L | ₹5 L | ₹5 L | ₹5 L | ₹0 | ₹0 | ₹5 Cr | ₹5 Cr | ₹0 | ₹0 |
| ₹144 Cr | ₹120 Cr | ₹93 Cr | ₹100 Cr | ₹583 Cr | ₹486 Cr | ₹128 Cr | ₹79 Cr | ₹74 Cr | ₹35 Cr | ₹15 Cr | ₹10 Cr |
| ₹141 Cr | ₹30 Cr | ₹18 Cr | ₹34 Cr | ₹12 Cr | ₹19 Cr | ₹25 Cr | ₹4 Cr | ₹28 Cr | ₹2 Cr | ₹35 Cr | ₹17 Cr |
| ₹4214 Cr | ₹3200 Cr | ₹2734 Cr | ₹2511 Cr | ₹2810 Cr | ₹2585 Cr | ₹2237 Cr | ₹1769 Cr | ₹1512 Cr | ₹1025 Cr | ₹976 Cr | ₹802 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — |
| ₹79 Cr | ₹67 Cr | ₹67 Cr | ₹60 Cr | ₹53 Cr | ₹40 Cr | ₹39 Cr | ₹23 Cr | ₹23 Cr | ₹21 Cr | ₹28 Cr | ₹25 Cr |
| ₹411 Cr | ₹292 Cr | ₹215 Cr | ₹194 Cr | ₹180 Cr | ₹134 Cr | ₹149 Cr | ₹164 Cr | ₹152 Cr | ₹107 Cr | ₹75 Cr | ₹53 Cr |
| ₹1130 Cr | ₹1122 Cr | ₹1175 Cr | ₹1278 Cr | ₹512 Cr | ₹289 Cr | ₹250 Cr | ₹266 Cr | ₹260 Cr | ₹470 Cr | ₹376 Cr | ₹304 Cr |
| ₹19 Cr | ₹24 Cr | ₹17 Cr | ₹19 Cr | ₹46 Cr | ₹23 Cr | ₹32 Cr | ₹23 Cr | ₹23 Cr | ₹17 Cr | ₹17 Cr | ₹10 Cr |
| ₹36 Cr | ₹28 Cr | ₹34 Cr | ₹28 Cr | ₹20 Cr | ₹16 Cr | ₹9 Cr | ₹14 Cr | ₹14 Cr | ₹13 Cr | ₹13 Cr | ₹17 Cr |
| ₹1675 Cr | ₹1533 Cr | ₹1509 Cr | ₹1579 Cr | ₹812 Cr | ₹502 Cr | ₹479 Cr | ₹490 Cr | ₹472 Cr | ₹627 Cr | ₹509 Cr | ₹410 Cr |
| ₹1048 Cr | ₹914 Cr | ₹891 Cr | ₹1007 Cr | ₹392 Cr | ₹97 Cr | ₹121 Cr | ₹212 Cr | ₹138 Cr | ₹355 Cr | ₹271 Cr | ₹196 Cr |
| ₹5889 Cr | ₹4733 Cr | ₹4243 Cr | ₹4090 Cr | ₹3622 Cr | ₹3087 Cr | ₹2716 Cr | ₹2259 Cr | ₹1984 Cr | ₹1653 Cr | ₹1485 Cr | ₹1212 Cr |
| ₹147 | ₹126 | ₹108 | ₹90 | ₹64 | ₹266 | ₹257 | ₹248 | ₹229 | ₹219 | ₹210 | ₹177 |
| ₹147 | ₹126 | ₹108 | ₹90 | ₹64 | ₹53 | ₹51 | ₹50 | ₹46 | ₹44 | ₹42 | ₹35 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹715 Cr | ₹647 Cr | ₹627 Cr | ₹449 Cr | ₹281 Cr | ₹32 Cr | ₹64 Cr | ₹95 Cr | ₹60 Cr | ₹85 Cr | ₹262 Cr | ₹226 Cr |
| ₹204 Cr | ₹240 Cr | ₹208 Cr | ₹199 Cr | ₹195 Cr | ₹189 Cr | ₹165 Cr | ₹120 Cr | ₹123 Cr | ₹107 Cr | ₹78 Cr | ₹65 Cr |
| -₹85 Cr | -₹100 Cr | -₹46 Cr | ₹103 Cr | -₹67 Cr | ₹37 Cr | ₹2 Cr | ₹3 Cr | -₹66 Cr | -₹19 Cr | -₹15 Cr | -₹24 Cr |
| ₹834 Cr | ₹788 Cr | ₹790 Cr | ₹751 Cr | ₹409 Cr | ₹258 Cr | ₹231 Cr | ₹218 Cr | ₹116 Cr | ₹173 Cr | ₹325 Cr | ₹267 Cr |
| ₹714 Cr | ₹624 Cr | ₹612 Cr | ₹645 Cr | ₹311 Cr | ₹242 Cr | ₹175 Cr | ₹150 Cr | ₹63 Cr | ₹115 Cr | ₹228 Cr | ₹213 Cr |
| -₹1089 Cr | -₹721 Cr | -₹441 Cr | -₹342 Cr | -₹421 Cr | -₹239 Cr | -₹87 Cr | -₹243 Cr | -₹69 Cr | -₹107 Cr | -₹241 Cr | -₹126 Cr |
| ₹272 Cr | -₹97 Cr | -₹514 Cr | ₹346 Cr | ₹160 Cr | -₹81 Cr | -₹88 L | ₹113 Cr | ₹9 Cr | -₹6 Cr | -₹7 Cr | -₹87 Cr |
| -₹103 Cr | -₹194 Cr | -₹343 Cr | ₹648 Cr | ₹50 Cr | -₹78 Cr | ₹87 Cr | ₹19 Cr | ₹3 Cr | ₹2 Cr | -₹20 Cr | -₹32 L |
| ₹230 Cr | ₹425 Cr | ₹767 Cr | ₹119 Cr | ₹69 Cr | ₹148 Cr | ₹60 Cr | ₹47 Cr | ₹44 Cr | ₹42 Cr | ₹62 Cr | ₹63 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹20,000 | ₹0 | ₹0 | ₹0 |
| ₹127 Cr | ₹230 Cr | ₹425 Cr | ₹767 Cr | ₹119 Cr | ₹69 Cr | ₹148 Cr | ₹66 Cr | ₹47 Cr | ₹44 Cr | ₹43 Cr | ₹62 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found
Global Health Share Price
1325.80+0.00 (+2.11%)
+4.02% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 5 out of 9 oscillators
RSI
53.36Neutral
STOCH %K
90.49Sell
MACD Level(12,26)
-24.21Sell
Ultimate Oscillator
57.65Buy
Aroon Oscillator
-76.00Sell
BOP
0.31Buy
CCI
108.32Sell
Williams %R
-9.51Sell
Momentum
45.60Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 7
Bearish signals: 2 out of 9 moving averages
EMA 9
1280.58Buy
SMA 9
1259.22Buy
EMA 21
1293.32Buy
SMA 21
1271.68Buy
EMA 50
1334.05Sell
SMA 50
1373.67Sell
EMA 200
1296.51Buy
SMA 200
1244.99Buy
WMA 20
1265.68Buy
Pivot
Pivot
Classic
Resistance 5
1557.43
Resistance 4
1493.33
Resistance 3
1429.23
Resistance 2
1365.13
Resistance 1
1331.77
Pivot
1301.03
Support 1
1267.67
Support 2
1236.93
Support 3
1172.83
Support 4
1108.73
Support 5
1044.63
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Global Health Share Price
1325.80+0.00 (+2.11%)
+4.02% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 33.00% | 33.00% | 33.01% | 33.01% | 33.01% | 33.01% |
| 9.92% | 9.46% | 10.15% | 10.54% | 11.41% | 11.54% |
| 1.04% | 0.86% | 0.85% | 0.87% | 1.14% | 1.54% |
| 15.97% | 16.03% | 13.91% | 13.12% | 11.83% | 10.66% |
| 40.07% | 40.65% | 42.08% | 42.46% | 42.61% | 43.25% |
Bulk & block deals
Name
Hdfc Mutual Fund
Sunil Sachdeva
Hdfc Mutual Fund
Sunil Sachdeva
Rj Corp Limited
Jm Financial Institutional Securities Limited
Jm Financial Institutional Securities Limited
Dunearn Investments Mauritius Pte Limited
The Jupiter Global Fund-Jupiter India Select
Jupiter South Asia Investment Company Limited
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 25 Jun 2026 | Purchase | 130 Cr | ₹1,300 | 10 L | Block | 0.37193 | BSE |
| 25 Jun 2026 | Sell | 130 Cr | ₹1,300 | 10 L | Block | 0.37193 | BSE |
| 25 May 2026 | Purchase | 122.50 Cr | ₹1,225 | 10 L | Block | 0.371952 | NSE |
| 25 May 2026 | Sell | 122.50 Cr | ₹1,225 | 10 L | Block | 0.371952 | NSE |
| 14 Feb 2024 | Purchase | 379.01 Cr | ₹1,315 | 28.82 L | Bulk | 1.07195 | BSE |
| 14 Feb 2024 | Sell | 394.51 Cr | ₹1,315.05 | 30 L | Bulk | 1.115761 | BSE |
| 14 Feb 2024 | Purchase | 394.57 Cr | ₹1,315.22 | 30 L | Bulk | 1.115761 | BSE |
| 14 Feb 2024 | Sell | 394.56 Cr | ₹1,315.20 | 30 L | Bulk | 1.115761 | BSE |
| 18 Jan 2024 | Purchase | 30.67 Cr | ₹1,030.05 | 2.98 L | Block | 0.110755 | BSE |
| 18 Jan 2024 | Sell | 30.67 Cr | ₹1,030.05 | 2.98 L | Block | 0.110755 | BSE |
Insider trading & SAST
Client name
Invesco Mutual Fund
Sunil Sachdeva
Sunil Sachdeva
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 Mar 2026 | Other | Acquisition | 0.37 | 5.02 | 0 | — | 10.02 L | 20 Feb 2026 | Market | 1,35,13,011 | SAST | 29(1) | — |
| 28 Oct 2025 | Other | Acquisition | 3.24 | 11.15 | 0 | — | 87.10 L | 30 Sep 2025 | Off Market Transfer | 2,99,91,884 | SAST | 29(2) | — |
| 24 Jun 2025 | Other | Acquisition | 7.92 | 11.27 | 0 | — | 2.13 Cr | 16 May 2025 | Off Market Transfer | 3,02,64,524 | SAST | 29(2) | — |
Global Health Share Price
1325.80+0.00 (+2.11%)
+4.02% past 1 Year
Global Health, operating under the Medanta brand, is engaged in the business of providing healthcare services. The company delivers a comprehensive range of services across several medical specialties, including cardiac
Corporate Actions
Date
Type
Details
Company details
Global Health Share Price
1325.80+0.00 (+2.11%)
+4.02% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Global Health Share Price
1325.80+0.00 (+2.11%)
+4.02% past 1 Year
News
Medanta Reports Strong Q2 EBITDA Growth With Improved Operating Margin
Equity
MEDANTA
Medanta Q2 Consolidated Net Profit Rises 39 Percent Year On Year
Equity
MEDANTA
Medanta Q2 Revenue Rises 34 Percent Year on Year To Rs 1,470 Crores
Equity
MEDANTA
Global Health Secures Land For New 350 Plus Bedded Hospital
Equity
MEDANTA
Global Health Schedules Analyst and Investor Meeting for September 25
Equity
MEDANTA
Investec starts Buy on Global Health with Rs 1,730 target price
Equity
MEDANTA
Global Health to host investor and analyst meetings on September 17-18
Equity
MEDANTA
Global Health plans investor and analyst meeting on September 14
Equity
MEDANTA
Global Health schedules analyst and investor meetings on 10 and 14 September
Equity
MEDANTA
Global Health to host analyst and investor meet on September 8
Equity
MEDANTA
Global Health MEDANTA schedules analyst and investor meet on August 21
Equity
MEDANTA
Global Health Ltd sees Rs 19.96 crores NSE block trade in MEDANTA
Equity
MEDANTA
Medanta expects stronger volume growth in Lucknow and Patna, higher Gurgaon expansion
Equity
MEDANTA
Global Health approves revised Guwahati hospital plan with 650 beds
Equity
MEDANTA
Global Health posts higher Q1 EBITDA with stable margin performance
Equity
MEDANTA
Global Health Q1 revenue surges while profit remains flat year on year
Equity
MEDANTA
Global Health schedules Q1 FY2025 earnings conference call for investors
Equity
MEDANTA
Global Health, Medanta operator to review Q1 FY26 results on July 30
Equity
MEDANTA
Global Health gets LoI from Government of Haryana
Equity
MEDANTA
Global Health Limited: Gets Intent Letter From Haryana Government To Set Up Medical College; Will Provide 150 Mbbs Seats At Medanta – The Medicity, Gurugram.
Equity
MEDANTA